Latanoprost E Timololo Eg

Latanoprost and Timolol, the active ingredients in Latanoprost Timolol, are a prostaglandin analog and a non‑selective beta blocker presented as ocular drops for eye use. The combination lowers intra‑ocular pressure and is indicated for open‑angle glaucoma and ocular hypertension in adult patients.

GNH USA supplies Latanoprost Timolol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost Timolol is employed in the management of ocular conditions that require reduction of intra‑ocular pressure. - Open‑angle glaucoma: lowers eye pressure to prevent optic nerve damage and visual field loss. - Ocular hypertension: reduces elevated eye pressure to lower the risk of progression to glaucoma.

Common Side Effects: - Eye irritation or burning sensation - Blurred vision - Redness of the conjunctiva - Dry eye or foreign‑body feeling

Serious or Rare Side Effects: - Increased iris pigmentation - Periorbital fat atrophy - Corneal edema or ulceration - Severe allergic reaction (e.g., angio‑edema) - Systemic beta‑blocker effects such as bradycardia or bronchospasm

Before initiating therapy, clinicians should consider several safety aspects. - Cardiovascular assessment: evaluate for bradycardia or heart block. - Respiratory status: avoid in patients with asthma or severe COPD. - Intra‑ocular pressure monitoring: ensure adequate pressure reduction after start. - Hypersensitivity check: discontinue if allergic reaction occurs. - Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost Timolol may interact with several medicines. Major Interactions (Avoid): - Non‑selective beta‑blocker antagonists (e.g., propranolol): additive systemic beta‑blockade. - Sympathomimetic eye drops (e.g., epinephrine): may diminish pressure‑lowering effect. - Carbonic anhydrase inhibitors: increased risk of ocular hypotension. - Other prostaglandin analogs: additive ocular side effects.

Moderate Interactions (Monitor Closely): - Systemic antihypertensives: monitor blood pressure for excessive lowering. - Bronchodilators: watch for bronchospasm in susceptible patients. - MAO inhibitors: potential interaction with timolol affecting heart rate.